Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker.
CONCLUSIONS: BPE of the contralateral breast is associated with breast cancer in several aspects, therefore it has been proposed as a tool to refine breast cancer decision-making process.
ADVANCES IN KNOWLEDGE: additional researches with standardized BPE assessment are needed to translate this emerging biomarker into clinical practice in the era of personalized medicine.
PMID: 33035073 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Rella R, Contegiacomo A, Bufi E, Mercogliano S, Belli P, Manfredi R Tags: Br J Radiol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Computers | Molecular Biology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology | Study | UK Health